GINA SNIDER: Open Payments
NPI 1578530002 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 67 payments from 16 companies in 2025. Trend: 2023 $1,115 · 2024 $1,255 · 2025 $991
Food & beverage: $991
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $309 |
| Novo Nordisk Inc | 13 | $275 |
| Lilly USA, LLC | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 5 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| PFIZER INC. | 2 | $35 |
| Lundbeck LLC | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Boston Scientific Corporation | 1 | $23 |
| Viatris Specialty LLC | 1 | $20 |
Products named: VRAYLAR, Wegovy, Ozempic, MOUNJARO, VOQUEZNA, QULIPTA, UBRELVY, XIFAXAN.
Industry payments across NC — which companies pay providers there.
